Bolondi 2001.
Study characteristics | |||
Patient Sampling | Between March 1989 and November 1991, a cohort of patients with liver cirrhosis and without HCC. Exclusion criteria were: (1) Child‐Pugh C class 16 in patients older than 60 years; (2) a previous diagnosis of focal liver lesion at US; and (3) a serum AFP level > 200 ng/dL. Patients were withdrawn from further surveillance when they were > 60 years old and belonged to Child‐Pugh C class, developed other neoplasms, or underwent orthotopic liver transplantation. Age range not reported. Males 62% |
||
Patient characteristics and setting | |||
Index tests | Cut‐off value 20 ng/mL | ||
Target condition and reference standard(s) | Serum AFP determinations and abdominal US, together with physical examination and routine biochemical tests, were repeated every six months. The diagnostic protocol for detection of a nodular liver lesion at US was based on contrast enhanced computed tomography (CT) and echo guided biopsy (when feasible, according to location of the nodule and bleeding risk). When a negative result was obtained after CT and echo guided biopsy, a strict follow up procedure was followed (three month intervals) and the nodule was rebiopsied when an increase in size was detected at US. | ||
Flow and timing | No information on interval between index test and reference standard | ||
Comparative | |||
Notes | This research was supported by grants of MURST (Italian Ministry for Technological and Scientifi Research). No information on conflicts of interest | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | No | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 2: Index Test (AFP) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 2: Index Test (US+AFP) | |||
DOMAIN 2: Index Test (US) | |||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | No | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | No | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | High risk |